156 related articles for article (PubMed ID: 33107190)
1. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
2. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
3. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.
Piao Y; Li Y; Xu Q; Liu JW; Xing CZ; Xie XD; Yuan Y
PLoS One; 2015; 10(8):e0136447. PubMed ID: 26317520
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
5. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
6. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
8. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
[TBL] [Abstract][Full Text] [Related]
9. Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
Bizhani F; Hashemi M; Danesh H; Nouralizadeh A; Narouie B; Bahari G; Ghavami S
EXCLI J; 2018; 17():3-13. PubMed ID: 29383014
[TBL] [Abstract][Full Text] [Related]
10. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
[TBL] [Abstract][Full Text] [Related]
11. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
[TBL] [Abstract][Full Text] [Related]
12. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
[TBL] [Abstract][Full Text] [Related]
13. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
[TBL] [Abstract][Full Text] [Related]
14. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
16. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic pseudogene DUXAP10 knockdown suppresses proliferation and invasion and induces apoptosis of papillary thyroid carcinoma cells by inhibition of Akt/mTOR pathway.
Li J; Jiang L; Liu Z; Li Y; Xu Y; Liu H
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1473-1483. PubMed ID: 32215944
[TBL] [Abstract][Full Text] [Related]
18. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
19. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma.
Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z
IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.
Wang Y; Lin L; Xu H; Li T; Zhou Y; Dan H; Jiang L; Liao G; Zhou M; Li L; Zeng X; Li J; Chen Q
J Oral Pathol Med; 2015 Jan; 44(1):45-50. PubMed ID: 25060489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
